BACKGROUND & AIMS: Colorectal cancers (CRCs) with microsatellite instability (MSI) and a mismatch repair (MMR) immunohistochemical deficit without hypermethylation of the MLH1 promoter are likely to be caused by Lynch syndrome. Some patients with these cancers have not been found to have pathogenic germline mutations and are considered to have Lynch-like syndrome (LLS). The aim of this study was to determine the risk of cancer in families of patients with LLS. METHODS: We studied a population-based cohort of 1705 consecutive patients, performing MSI tests and immunohistochemical analyses of MMR proteins. Patients were diagnosed with Lynch syndrome when they were found to have pathogenic germline mutations. Patients with MSI and loss of MSH2...
AbstractFamilies at high risk for Lynch syndrome can effectively be recognised by microsatellite ins...
Regular colonoscopy even with short intervals does not prevent all colorectal cancers (CRC) in Lynch...
Recent work has provided evidence for genetic and molecular heterogeneity in colorectal cancers (CRC...
Background & Aims: Colorectal cancers (CRCs) with microsatellite instability (MSI) and a mismatch re...
Lynch syndrome (LS) is one of the most prevalent hereditary cancer syndromes in humans and accounts ...
Colorectal cancer is the second most common cancer in women and the third most common cancer in men...
Lynch syndrome (LS) is a common cause of hereditary colorectal cancer (CRC). Some CRC patients devel...
Background & Aims: Lynch syndrome (LS) is an autosomal dominant disorder and is caused by mutations ...
CONTEXT: Lynch syndrome is the most common form of hereditary colorectal cancer (CRC) and is caused ...
BACKGROUND & AIMS: Two percent to 4% of all cases of colorectal cancer (CRC) are associated with Lyn...
BACKGROUND & AIMS: Two percent to 4% of all cases of colorectal cancer (CRC) are associated with...
Lynch Syndrome (LS) is the most common of the hereditary colorectal cancer (CRC) syndromes. It is ca...
BACKGROUND & AIMS: Two percent to 4% of all cases of colorectal cancer (CRC) are associated with Lyn...
BACKGROUND & AIMS: Lynch syndrome is a form of hereditary colorectal cancer (CRC) caused by pathogen...
Lynch syndrome is a hereditary cancer‐predisposing syndrome caused by germline defects in DNA mismat...
AbstractFamilies at high risk for Lynch syndrome can effectively be recognised by microsatellite ins...
Regular colonoscopy even with short intervals does not prevent all colorectal cancers (CRC) in Lynch...
Recent work has provided evidence for genetic and molecular heterogeneity in colorectal cancers (CRC...
Background & Aims: Colorectal cancers (CRCs) with microsatellite instability (MSI) and a mismatch re...
Lynch syndrome (LS) is one of the most prevalent hereditary cancer syndromes in humans and accounts ...
Colorectal cancer is the second most common cancer in women and the third most common cancer in men...
Lynch syndrome (LS) is a common cause of hereditary colorectal cancer (CRC). Some CRC patients devel...
Background & Aims: Lynch syndrome (LS) is an autosomal dominant disorder and is caused by mutations ...
CONTEXT: Lynch syndrome is the most common form of hereditary colorectal cancer (CRC) and is caused ...
BACKGROUND & AIMS: Two percent to 4% of all cases of colorectal cancer (CRC) are associated with Lyn...
BACKGROUND & AIMS: Two percent to 4% of all cases of colorectal cancer (CRC) are associated with...
Lynch Syndrome (LS) is the most common of the hereditary colorectal cancer (CRC) syndromes. It is ca...
BACKGROUND & AIMS: Two percent to 4% of all cases of colorectal cancer (CRC) are associated with Lyn...
BACKGROUND & AIMS: Lynch syndrome is a form of hereditary colorectal cancer (CRC) caused by pathogen...
Lynch syndrome is a hereditary cancer‐predisposing syndrome caused by germline defects in DNA mismat...
AbstractFamilies at high risk for Lynch syndrome can effectively be recognised by microsatellite ins...
Regular colonoscopy even with short intervals does not prevent all colorectal cancers (CRC) in Lynch...
Recent work has provided evidence for genetic and molecular heterogeneity in colorectal cancers (CRC...